The motivation behind Seahawks’ Russell Wilson visiting Seattle...
October 4, 2018

Seattle Children’s reaches new cancer immunotherapy milestone

Jean Enerson, Seattle Children’s board member and co-chair of the It Starts with Yes: The Campaign for Seattle Children’s, writes in a guest blog: “From covering the opening of the first T-cell immunotherapy trial when I was an anchor at KING 5 TV, to now seeing this therapy being tested in seven open clinical trials at Seattle Children’s and applied to a variety of cancers, I’ve been amazed to watch the enormous strides researchers have made in the field over a few short years.”

Jean Enerson, Seattle Children’s board member and co-chair of the It Starts with Yes: The Campaign for Seattle Children’s, writes in a guest blog: “From covering the opening of the first T-cell immunotherapy trial when I was an anchor at KING 5 TV, to now seeing this therapy being tested in seven open clinical trials at Seattle Children’s and applied to a variety of cancers, I’ve been amazed to watch the enormous strides researchers have made in the field over a few short years.” She adds, “On Oct. 12, I will witness yet another major milestone – Seattle Children’s will bring their groundbreaking therapies to a global stage. Seattle Children’s will convene in London with several other children’s hospitals from around the world to share and discuss the latest innovations in pediatric health, including the promise of cancer immunotherapy, with the aim of further moving the needle on the latest advancements. But no one has more hope for this therapy than the children and teens who may one day rely on it, or those who understand the harsh reality of current treatments; children like Avery Berg.”

Source: On the Pulse